Stay updated on ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial
Sign up to get notified when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.

Latest updates to the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision history updated from v3.4.1 to v3.4.2. This is a metadata/version update and does not modify study details shown on the page.SummaryDifference0.0%

- Check32 days agoChange Detected- The site revision now shows Revision: v3.4.1. - The previous revision v3.4.0 has been removed.SummaryDifference0.0%

- Check46 days agoChange DetectedAdded a visible 'Last Update Posted' timestamp and removed the 'Last Update Posted (Estimated)' label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page now shows Revision: v3.3.4; the previous Revision: v3.3.3 was removed. This change does not alter study details, eligibility criteria, locations, or primary outcomes visible on the page.SummaryDifference0.0%

- Check82 days agoChange DetectedThe Locations section was expanded to include a comprehensive, multi-region list of study sites across US states, Canadian provinces, and other regions, replacing the prior listing.SummaryDifference2%

Stay in the know with updates to ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.